Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the treatment of early approximal carious lesions compared to fluoride.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2014
CompletedFirst Posted
Study publicly available on registry
April 2, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2017
CompletedJuly 18, 2018
July 1, 2018
3 years
March 21, 2014
July 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Opaqueness on X-Ray
The primary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 0 to Day 365 between test and control group.
Day 360
Secondary Outcomes (1)
Additional benefit of a second Curodont Repair application
Day 720
Study Arms (2)
Curodont Repair
EXPERIMENTALApplication on Day 0 and Day 360
Fluoride
ACTIVE COMPARATORApplication on Day 0, Day 180, Day 360, Day 540
Interventions
Self-assembling peptide, biomimetic re-mineralisation Application on Day 0 and Day 360
Eligibility Criteria
You may qualify if:
- Two approximal carious lesions on different teeth with at least one tooth in between
- Both study lesions must not require an invasive treatment
- Size and form of the lesions: the lesions must be fully visible and assessable on radiographs
- The two carious lesions must fall into classes:
- D2 (inner half of enamel)
- D3 (outer part of dentine) but only if very little dentine is involved (enamel-dentine junction)
- Able and willing to observe good oral hygiene throughout the study
- Age ≥ 18 years and ≤ 65 years
- Willing and able to attend the on-study visits
- Willing and able to understand all study-related procedures
- Written informed consent before participation in the study
You may not qualify if:
- The two study test lesions are located on adjacent teeth
- Fluoride varnish application \< 3 months prior to study treatment
- Tooth with numerous carious lesions
- Evidence of tooth erosion
- History of head and neck illnesses (e.g. head/neck cancer)
- Any pathology or concomitant medication affecting salivary flow or dry mouth
- Any metabolic disorders affecting bone turnover
- Patient suffers from diabetes
- Concurrent participation in another clinical trial
- Women who are breast-feeding, pregnant or who plan a pregnancy during the study
- Women of childbearing potential who declare being unwilling or unable to practice contraception such as hormonal contraceptives, sexual abstinence or intercourse with a vasectomised partner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Credentis AGlead
Study Sites (1)
Zahnheilkunde Seifert Gmbh
Sirnach, Thurgau, 8370, Switzerland
Related Publications (1)
Brunton PA, Davies RP, Burke JL, Smith A, Aggeli A, Brookes SJ, Kirkham J. Treatment of early caries lesions using biomimetic self-assembling peptides--a clinical safety trial. Br Dent J. 2013 Aug;215(4):E6. doi: 10.1038/sj.bdj.2013.741.
PMID: 23969679BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathias Seifert, Med. dent.
Zahnheilkunde Seifert Gmbh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2014
First Posted
April 2, 2014
Study Start
July 1, 2014
Primary Completion
June 26, 2017
Study Completion
June 26, 2017
Last Updated
July 18, 2018
Record last verified: 2018-07